By Cecilia Butini 
 

The European Medicines Agency said Friday that its human medicines committee has adopted recommendations to increase manufacturing capacity and supply of Covid-19 vaccines in the European Union.

The agency said it has approved an increase in batch size and process scale-up at Pfizer Inc.'s manufacturing site in Puurs, Belgium, a move which is expected to have a "significant" impact on the supply of the vaccine it developed with BioNTech SE.

The agency's committee for medicinal products for human use also recommended the approval of a new filling line at Moderna Inc.'s manufacturing site in Rovi, Spain, the EMA said.

 

Write to Cecilia Butini at cecilia.butini@wsj.com

 

(END) Dow Jones Newswires

April 23, 2021 09:31 ET (13:31 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.